PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 7.65
-0.04 (-0.52%)
Aug 26, 2026, 1:42 PM CST
PlexBio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 137.57 | 127.1 | 128.06 | 167.18 | 191.19 | 124.94 | |
Revenue Growth | -10.12% | -0.76% | -23.40% | -12.56% | 53.02% | 23.28% |
Cost of Revenue | 90.88 | 86.68 | 78.8 | 104.71 | 132.19 | 86.38 |
Gross Profit | 46.69 | 40.41 | 49.26 | 62.47 | 59 | 38.56 |
Selling, General & Admin | 50.19 | 53.56 | 59.5 | 63.65 | 53.32 | 60.51 |
Research & Development | 51.21 | 52.5 | 69.29 | 62.97 | 72.61 | 113.31 |
Operating Expenses | 101.4 | 106.06 | 128.79 | 126.62 | 125.93 | 173.82 |
Operating Income | -54.71 | -65.65 | -79.53 | -64.15 | -66.94 | -135.26 |
Interest Expense | -0.2 | -0.27 | -0.16 | -0.26 | -0.17 | -0.23 |
Interest & Investment Income | 7.35 | 7.99 | 9.58 | 8.27 | 3.01 | 2.31 |
Currency Exchange Gain (Loss) | -4.63 | -4.63 | 7.84 | -2.88 | 10.06 | -2.01 |
Other Non Operating Income (Expenses) | 13.82 | 0.09 | 0.63 | 0.49 | 0.9 | 4.08 |
EBT Excluding Unusual Items | -38.38 | -62.47 | -61.63 | -58.53 | -53.14 | -131.11 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.48 |
Pretax Income | -38.38 | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 |
Net Income | -38.38 | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 |
Net Income to Common | -38.38 | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 103 | 104 | 104 | 104 | 104 | 104 |
Shares Outstanding (Diluted) | 103 | 104 | 104 | 104 | 104 | 104 |
Shares Change | -0.63% | - | - | - | 0.11% | 0.51% |
EPS (Basic) | -0.37 | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 |
EPS (Diluted) | -0.37 | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -47.35 | -79.52 | -8.64 | -32.11 | -73.02 | -95.94 |
Free Cash Flow Per Share | -0.46 | -0.77 | -0.08 | -0.31 | -0.70 | -0.93 |
Gross Margin | 33.94% | 31.80% | 38.46% | 37.37% | 30.86% | 30.86% |
Operating Margin | -39.77% | -51.65% | -62.10% | -38.38% | -35.01% | -108.26% |
Profit Margin | -27.89% | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
Free Cash Flow Margin | -34.42% | -62.57% | -6.75% | -19.21% | -38.19% | -76.78% |
EBITDA | -48.22 | -58.06 | -69.67 | -55.06 | -55.76 | -121.46 |
EBITDA Margin | -35.05% | -45.68% | -54.40% | -32.93% | -29.17% | -97.21% |
D&A For EBITDA | 6.49 | 7.58 | 9.86 | 9.09 | 11.17 | 13.8 |
EBIT | -54.71 | -65.65 | -79.53 | -64.15 | -66.94 | -135.26 |
EBIT Margin | -39.77% | -51.65% | -62.10% | -38.37% | -35.01% | -108.26% |